相关实验视频
Updated: Sep 13, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.4K
慢性病中骨折风险:解决一个被忽视的并发症
Guido Gembillo1, Concetto Sessa2, Walter Morale2
1Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
Metabolites
|July 25, 2025
概括
患有慢性病 (CKD) 的患者因骨脆弱而面临高骨折风险. 早期诊断和量身定制的治疗对于管理骨健康和预防骨折在这个人群中至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨折风险是慢性病 (CKD) 的重要并发症,特别是G3-G5D阶段.
- 慢性结核病 - 矿物质和骨疾病 (CKD-MBD) 和骨质疏松症重叠,导致复杂的骨变化并增加脆弱性骨折的可能性.
- 患有骨质疏松症的CKD患者骨折的可能性超过2.5倍,晚期的风险高达四倍.
研究的目的:
- 审查CKD患者骨脆弱性的病理生理学,诊断挑战和治疗选择.
- 要突出像BMD和TBS这样的诊断工具在高级CKD中的不足利用.
- 强调需要特定阶段的多学科管理策略.
主要方法:
- 对CKD-MBD,骨质疏松症和CKD患者骨折风险的现有文献的综述.
- 分析诊断挑战和使用不足的评估工具 (BMD,TBS,生化标志物).
- 探索当前和新兴的治疗策略,包括补充剂,抗吸收剂和合成代谢剂.
主要成果:
- 在CKD患者中,骨折风险显著增加,部骨折导致发病率和死亡率增加.
- 对于骨健康的诊断工具在晚期CKD阶段未得到充分利用.
- 有效的管理需要基于骨周转和CKD阶段的个性化,特定阶段的方法.
结论:
- 积极的骨健康维护对于预防CKD患者骨折和并发症至关重要.
- 以最新建议和跨学科方法为指导的个性化护理对于降低骨折风险至关重要.
- 需要进一步的研究来完善风险评估工具和治疗方案,以治疗CKD骨脆弱性.
相关概念视频
Chronic Kidney Disease I: Introduction
73
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
73
Chronic Kidney Disease II: Clinical Manifestations
96
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
96
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Chronic Kidney Disease IV: Nursing Management
59
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
59
Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94

